Open access
97
Views
16
CrossRef citations to date
0
Altmetric
Review
Interpreting patient-reported outcomes from clinical trials in COPD: a discussion
Paul W Jones1 Institute for Infection and Immunity, University of London, London;2 Global Respiratory Franchise, GlaxoSmithKline, Uxbridge, UKCorrespondence[email protected]
, Stephen Rennard3 Division of Pulmonary, Critical Care, Sleep and Allergy, Nebraska Medical Center, Omaha, NE, USA;4 Clinical Discovery Unit, AstraZeneca, Cambridge
, Maggie Tabberer5 Global R&D, GlaxoSmithKline, Uxbridge
, John H Riley2 Global Respiratory Franchise, GlaxoSmithKline, Uxbridge, UK
, Mitra Vahdati-Bolouri2 Global Respiratory Franchise, GlaxoSmithKline, Uxbridge, UK
& Neil C Barnes2 Global Respiratory Franchise, GlaxoSmithKline, Uxbridge, UK;6 William Harvey Institute, Bart’s and the London School of Medicine and Dentistry, London, UK
Pages 3069-3078
|
Published online: 07 Dec 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.